logo
Lightning Round: Monster Beverage is a smoking hot stock, says Jim Cramer

Lightning Round: Monster Beverage is a smoking hot stock, says Jim Cramer

CNBC9 hours ago

'Mad Money' host Jim Cramer weighs in on stocks including: Nebius, Sweetgreen, Okta, Monster Beverage, and McDonald's.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Oppenheimer Raises Okta (OKTA) Price Target, Maintains Outperform Rating
Oppenheimer Raises Okta (OKTA) Price Target, Maintains Outperform Rating

Yahoo

timean hour ago

  • Yahoo

Oppenheimer Raises Okta (OKTA) Price Target, Maintains Outperform Rating

Okta, Inc. (NASDAQ:OKTA) is one of . Oppenheimer analyst Ittai Kidron has raised the firm's price target on Okta, Inc. (NASDAQ:OKTA) to $135 from $125, maintaining an Outperform rating on the shares. The upgrade follows Okta's strong fourth-quarter results and an upward revision to its guidance, driven by broad-based momentum across several key areas. According to Oppenheimer, the company saw solid trends among its large customers, contributing to robust growth. Notably, Okta recorded a record contribution from its Auth0 segment, further enhancing its revenue mix. Additionally, growing product cross-sell activity highlighted the company's expanding product portfolio and customer engagement. A mobile application developer programming on a tablet, illustrating the power of the company's adaptive multi-factor authentication. The analyst praised Okta's overall execution during the quarter, calling it an 'excellent quarter' that showcased the benefits of recent sales adjustments and the company's increasing product breadth. These factors, combined with a favorable market environment, position Okta well for continued growth. Oppenheimer expressed a bullish outlook on Okta's prospects, establishing the stock as a top pick within its coverage. The firm sees a potential multi-quarter re-rating driven by the company's strong sales execution and expanding portfolio. Investors may view Okta's improving fundamentals and strategic progress as key reasons for confidence in the stock's future performance. The updated price target reflects Oppenheimer's belief that Okta is well-positioned to capitalize on its momentum and deliver sustained growth in the coming quarters. While we acknowledge the potential of OKTA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OKTA and that has 100x upside potential, check out our report about this cheapest AI NEXT: 10 Best Small Cap Tech Stocks With Biggest Upside Potential and 7 Most Popular AI Penny Stocks Under $5 To Avoid. Disclosure: None.

Jim Cramer on Jabil: 'I Am Again Going to Bless It'
Jim Cramer on Jabil: 'I Am Again Going to Bless It'

Yahoo

timean hour ago

  • Yahoo

Jim Cramer on Jabil: 'I Am Again Going to Bless It'

Jabil Inc. (NYSE:JBL) is one of the 14 stocks Jim Cramer recently shared insights on. Answering a caller's query about the stock during the lightning round, Cramer stated: 'Jabil is so terrific that even though it's up on a spike… I am again going to bless it. Why? Because it only sells at 22 times earnings, and it's the kind of company you need to deal with right now. They'll understand all the tariff problems and they'll help you.' A technician overseeing an application-specific integrated circuit design, etched on a metallic plate. Jabil (NYSE:JBL) delivers comprehensive manufacturing and design services, including electronics and electro-mechanical product development, prototyping, validation, and assembly. Additionally, the company provides testing, production management, and consulting solutions across various manufacturing processes. Back in February, Cramer commented: 'What in the world has gotten into the stock of Jabil? This company has been on fire ever since it reported a tremendous quarter back in December. It's up more than 25% in the past two months, setting foot into fresh all-time high territory. I've always loved this company. […] 'They're not just a manufacturing company, they're an engineering and supply chain powerhouse. They build semiconductor fab equipment, testing equipment, silicon photonics, servers, and racks. Amazon just did a deal with them, cementing a hugely important relationship.' While we acknowledge the potential of JBL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Jim Cramer on Hims & Hers: 'You Gotta Generate Some Discipline Here'
Jim Cramer on Hims & Hers: 'You Gotta Generate Some Discipline Here'

Yahoo

timean hour ago

  • Yahoo

Jim Cramer on Hims & Hers: 'You Gotta Generate Some Discipline Here'

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the importance of discipline over conviction, Cramer commented: 'No matter how much you love these speculative winners, you don't have a gain until you actually ring the register. At the end of last week, for example, Hims & Hers Health, the online healthcare company, was trading at $64. But then yesterday, the stock fell 22 bucks for an almost 35% decline… What I care about is that this stock… [has] almost tripled in two months. If you owned Hims & Hers up almost 200% and you hadn't sold any at that point, you were being a knucklehead. A nurse in a telehealth platform talking with a patient on video call for consultation. Hims & Hers Health (NYSE:HIMS) operates a telehealth platform that delivers prescription and non-prescription health and wellness products. The company's products include medication, skin care, sexual health, hair care, and wellness items, supported by ongoing care from licensed healthcare professionals. While we acknowledge the potential of HIMS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store